PMC:7033706 / 7453-7668 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"199","span":{"begin":200,"end":208},"obj":"Species"},{"id":"204","span":{"begin":71,"end":79},"obj":"Species"},{"id":"206","span":{"begin":160,"end":179},"obj":"Disease"}],"attributes":[{"id":"A199","pred":"tao:has_database_id","subj":"199","obj":"Tax:694009"},{"id":"A204","pred":"tao:has_database_id","subj":"204","obj":"Tax:694009"},{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"on. One of the rapid approaches is to evaluate the currently available SARS-CoV neutralizing antibodies with cross-neutralizing and protection activity against 2019-nCoV infection. We have shown that SARS-CoV S-RBD-"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T36","span":{"begin":71,"end":79},"obj":"Disease"},{"id":"T37","span":{"begin":160,"end":179},"obj":"Disease"},{"id":"T38","span":{"begin":170,"end":179},"obj":"Disease"},{"id":"T39","span":{"begin":200,"end":208},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"on. One of the rapid approaches is to evaluate the currently available SARS-CoV neutralizing antibodies with cross-neutralizing and protection activity against 2019-nCoV infection. We have shown that SARS-CoV S-RBD-"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T95","span":{"begin":143,"end":151},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"on. One of the rapid approaches is to evaluate the currently available SARS-CoV neutralizing antibodies with cross-neutralizing and protection activity against 2019-nCoV infection. We have shown that SARS-CoV S-RBD-"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":4,"end":180},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"on. One of the rapid approaches is to evaluate the currently available SARS-CoV neutralizing antibodies with cross-neutralizing and protection activity against 2019-nCoV infection. We have shown that SARS-CoV S-RBD-"}